These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26799847)

  • 1. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease.
    Farzaei MH; Bahramsoltani R; Abdolghaffari AH; Sodagari HR; Esfahani SA; Rezaei N
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):745-58. PubMed ID: 26799847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of nutraceutical compounds in inflammatory bowel disease.
    Larussa T; Imeneo M; Luzza F
    World J Gastroenterol; 2017 Apr; 23(14):2483-2492. PubMed ID: 28465632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease.
    Ghattamaneni NKR; Panchal SK; Brown L
    Pharmacol Res; 2018 Jun; 132():99-107. PubMed ID: 29680446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease.
    Sodagari HR; Farzaei MH; Bahramsoltani R; Abdolghaffari AH; Mahmoudi M; Rezaei N
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):807-20. PubMed ID: 25586636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota Modulation and Anti-Inflammatory Properties of Dietary Polyphenols in IBD: New and Consolidated Perspectives.
    Santino A; Scarano A; De Santis S; De Benedictis M; Giovinazzo G; Chieppa M
    Curr Pharm Des; 2017; 23(16):2344-2351. PubMed ID: 28176667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on dietary consideration in inflammatory bowel disease: anthocyanins and more.
    Farzaei MH; El-Senduny FF; Momtaz S; Parvizi F; Iranpanah A; Tewari D; Naseri R; Abdolghaffari AH; Rezaei N
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1007-1024. PubMed ID: 30136591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons.
    Filimon AM; Negreanu L; Doca M; Ciobanu A; Preda CM; Vinereanu D
    World J Gastroenterol; 2015 Sep; 21(33):9688-92. PubMed ID: 26361415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of drugs to target interactions between leukocytes and endothelial cells and treatment algorithms for inflammatory bowel diseases.
    Danese S; Panés J
    Gastroenterology; 2014 Nov; 147(5):981-9. PubMed ID: 25220794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut biofilm forming bacteria in inflammatory bowel disease.
    Srivastava A; Gupta J; Kumar S; Kumar A
    Microb Pathog; 2017 Nov; 112():5-14. PubMed ID: 28942174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory pathways of importance for management of inflammatory bowel disease.
    Pedersen J; Coskun M; Soendergaard C; Salem M; Nielsen OH
    World J Gastroenterol; 2014 Jan; 20(1):64-77. PubMed ID: 24415859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of inflammatory bowel diseases: functional role of T cells and T cell homing.
    Zundler S; Neurath MF
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S19-28. PubMed ID: 26458165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease.
    Nie Y; Lin Q; Luo F
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28654020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin A and inflammatory bowel diseases: from cellular studies and animal models to human disease.
    Barbalho SM; Goulart RA; Batista GLDSA
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):25-35. PubMed ID: 30791845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.
    Degasperi E; Caprioli F; El Sherif O; Back D; Colombo M; Aghemo A
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1373-1383. PubMed ID: 27718758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches.
    Abraham BP; Ahmed T; Ali T
    Handb Exp Pharmacol; 2017; 239():115-146. PubMed ID: 28233184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet and nutritional factors in inflammatory bowel diseases.
    Owczarek D; Rodacki T; Domagała-Rodacka R; Cibor D; Mach T
    World J Gastroenterol; 2016 Jan; 22(3):895-905. PubMed ID: 26811635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disrupted regulatory T cell homeostasis in inflammatory bowel diseases.
    Pedros C; Duguet F; Saoudi A; Chabod M
    World J Gastroenterol; 2016 Jan; 22(3):974-95. PubMed ID: 26811641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interleukin-22 in inflammatory bowel disease.
    Li LJ; Gong C; Zhao MH; Feng BS
    World J Gastroenterol; 2014 Dec; 20(48):18177-88. PubMed ID: 25561785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.
    Quetglas EG; Mujagic Z; Wigge S; Keszthelyi D; Wachten S; Masclee A; Reinisch W
    World J Gastroenterol; 2015 Nov; 21(44):12519-43. PubMed ID: 26640330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.